MoonLake Immunotherapeutics (MLTX)

18.49 +4.15 (+28.94%) USD  |  NASDAQ  |  Jan 09, 16:00
19.38 +0.89 (+4.81%) After-Hours: 20:00
More

MoonLake Immunotherapeutics Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for MLTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
Baxter International, Inc. Upgrade
aTyr Pharma, Inc. Upgrade
BeOne Medicines Ltd. Upgrade
AC Immune SA Upgrade
CRISPR Therapeutics AG Upgrade

Return on Net Operating Assets Related Metrics

Return on Equity Upgrade
Return on Assets Upgrade
Return on Invested Capital Upgrade